Ibio, INC Form 4 insider transactions

Director William D. Clark purchased 1,838 shares of iBio, Inc. common stock at a price of $2.72 per share on January 10, 2025.

Antonio Bernardino Guimaraes Parada, a director of iBio, Inc., acquired 183,823 shares of common stock through MagicRoad SGPS, Unipessoal LDA on January 10, 2025.

Director Gary Sender purchased 9,191 shares of iBio, Inc. common stock at $2.72 per share on January 10, 2025.

iBio director Antonio Bernardino Guimaraes Parada acquired 12,600 stock options at an exercise price of $2.45, vesting over three years.

iBio director Gary Sender acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

iBio director Evert B. Schimmelpennink acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

Alexandra Kropotova, a director at iBio, Inc., acquired 18,900 stock options on November 21, 2024, according to a recent SEC filing.

Director William D. Clark of iBio, Inc. acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.

Director David Arkowitz acquired 12,600 stock options in iBio, Inc. on November 21, 2024.

iBio's Chief Executive Officer and Chief Scientific Officer, Martin Brenner, acquired stock options on May 9, 2024.

Felipe Duran, CFO of iBio, Inc., was granted stock options to purchase 90,000 shares of common stock on May 9, 2024.

Felipe Duran, CFO of iBio, Inc., reports the acquisition of stock options.